FR2373288A1 - Preparation pharmaceutique a liberation prolongee - Google Patents
Preparation pharmaceutique a liberation prolongeeInfo
- Publication number
- FR2373288A1 FR2373288A1 FR7735611A FR7735611A FR2373288A1 FR 2373288 A1 FR2373288 A1 FR 2373288A1 FR 7735611 A FR7735611 A FR 7735611A FR 7735611 A FR7735611 A FR 7735611A FR 2373288 A1 FR2373288 A1 FR 2373288A1
- Authority
- FR
- France
- Prior art keywords
- pharmaceutical preparation
- release pharmaceutical
- long
- drug
- sustained release
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 238000013268 sustained release Methods 0.000 abstract 2
- 239000012730 sustained-release form Substances 0.000 abstract 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 abstract 1
- 230000004888 barrier function Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 238000009792 diffusion process Methods 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 239000003456 ion exchange resin Substances 0.000 abstract 1
- 229920003303 ion-exchange polymer Polymers 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000002459 sustained effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74532576A | 1976-11-26 | 1976-11-26 | |
| US80010577A | 1977-05-24 | 1977-05-24 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2373288A1 true FR2373288A1 (fr) | 1978-07-07 |
| FR2373288B1 FR2373288B1 (enExample) | 1980-06-13 |
Family
ID=27114439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7735611A Granted FR2373288A1 (fr) | 1976-11-26 | 1977-11-25 | Preparation pharmaceutique a liberation prolongee |
Country Status (21)
| Country | Link |
|---|---|
| JP (1) | JPS609697B2 (enExample) |
| AR (1) | AR218047A1 (enExample) |
| AT (1) | AT359197B (enExample) |
| AU (1) | AU511080B2 (enExample) |
| BE (1) | BE861141A (enExample) |
| CA (1) | CA1086226A (enExample) |
| CH (1) | CH639560A5 (enExample) |
| DE (1) | DE2752728C2 (enExample) |
| DK (1) | DK150534C (enExample) |
| FI (1) | FI65910C (enExample) |
| FR (1) | FR2373288A1 (enExample) |
| GB (1) | GB1544761A (enExample) |
| GR (1) | GR61724B (enExample) |
| IE (1) | IE45998B1 (enExample) |
| IL (1) | IL53462A (enExample) |
| LU (1) | LU78584A1 (enExample) |
| NL (1) | NL182283C (enExample) |
| NO (1) | NO147626C (enExample) |
| NZ (1) | NZ185772A (enExample) |
| PT (1) | PT67323B (enExample) |
| SE (1) | SE426781B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2929456A1 (de) | 1979-07-20 | 1981-02-05 | Lentia Gmbh | Zusammensetzung mit verlaengerter broncholytischer und tokolytischer wirksamkeit, ein verfahren zu deren herstellung und broncholytisch und tokolytisch wirkendes mittel |
| CA1236023A (en) * | 1984-07-18 | 1988-05-03 | Yegnaswami Raghunathan | Controlled release pharmaceutical preparations |
| US4692462A (en) * | 1985-03-18 | 1987-09-08 | Menley & James Laboratories, Ltd. | Compositions and method of controlling transdermal penetration of topical and systemic agents |
| US5612059A (en) * | 1988-08-30 | 1997-03-18 | Pfizer Inc. | Use of asymmetric membranes in delivery devices |
| US5188825A (en) * | 1989-12-28 | 1993-02-23 | Iles Martin C | Freeze-dried dosage forms and methods for preparing the same |
| US5876752A (en) * | 1990-08-07 | 1999-03-02 | Pfizer Inc. | Use of interfacially-polymerized membranes in delivery devices |
| US5436011A (en) * | 1993-04-16 | 1995-07-25 | Bristol-Myers Squibb Company | Solid pharmaceutical dosage form and a method for reducing abrasion |
| US20130230587A1 (en) * | 2010-11-10 | 2013-09-05 | Rubicon Research Private Limited | Sustained release compositions |
| FR3059903B1 (fr) * | 2016-12-08 | 2019-03-22 | Salsarulo Pharma | Medicament oral comprenant un laxatif osmotique incorpore dans une matrice a base de matieres grasses vegetales |
| EP3694555A4 (en) | 2017-10-09 | 2021-07-07 | Rhodes Pharmaceuticals L.P. | RESINATE-BASED PHARMACEUTICAL COMPOSITIONS AND THEIR MANUFACTURING AND USE PROCESSES |
| WO2020234842A1 (en) * | 2019-05-23 | 2020-11-26 | G.D Societa' Per Azioni | Filling unit to fill a container, in particular a cartridge, with a liquid product of the pharmaceutical industry |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB824337A (en) * | 1955-08-08 | 1959-11-25 | R J Strasenburgh Co | Therapeutic compositions |
| US3153613A (en) * | 1957-02-13 | 1964-10-20 | Ici Ltd | Tetra-and penta-methyl piperidine antihypertensive compositions and therapy |
| US3158538A (en) * | 1961-02-23 | 1964-11-24 | White Lab Inc | Antidiarrheal compositions and method of using |
| GB982150A (en) * | 1961-09-29 | 1965-02-03 | Glaxo Group Ltd | Therapeutic resin complexes |
| FR2004105A1 (fr) * | 1968-03-15 | 1969-11-21 | Philips Nv | Preparations pharmaceutiques |
| DE1944693A1 (de) * | 1968-09-03 | 1970-04-30 | Banker Dr Gilbert S | Arzneimittelzubereitung |
| DE1944694A1 (de) * | 1968-09-03 | 1970-05-06 | Banker Dr Gilbert S | Pharmazeutische Zubereitung |
| US3594470A (en) * | 1968-02-19 | 1971-07-20 | Abbott Lab | Chewable tablets including coated particles of pseudoephedrine-weak cation exchange resin |
| FR2242076A1 (enExample) * | 1973-08-28 | 1975-03-28 | Hoechst Ag |
-
1977
- 1977-11-24 BE BE182882A patent/BE861141A/xx not_active IP Right Cessation
- 1977-11-24 NZ NZ185772A patent/NZ185772A/xx unknown
- 1977-11-24 JP JP52140093A patent/JPS609697B2/ja not_active Expired
- 1977-11-24 IL IL53462A patent/IL53462A/xx unknown
- 1977-11-24 FI FI773568A patent/FI65910C/fi not_active IP Right Cessation
- 1977-11-24 CA CA291,664A patent/CA1086226A/en not_active Expired
- 1977-11-24 GR GR54861A patent/GR61724B/el unknown
- 1977-11-24 GB GB48997/77A patent/GB1544761A/en not_active Expired
- 1977-11-25 AU AU30986/77A patent/AU511080B2/en not_active Expired
- 1977-11-25 LU LU78584A patent/LU78584A1/xx unknown
- 1977-11-25 AT AT848077A patent/AT359197B/de not_active IP Right Cessation
- 1977-11-25 NL NLAANVRAGE7712996,A patent/NL182283C/xx not_active IP Right Cessation
- 1977-11-25 CH CH1450177A patent/CH639560A5/de not_active IP Right Cessation
- 1977-11-25 NO NO774051A patent/NO147626C/no unknown
- 1977-11-25 FR FR7735611A patent/FR2373288A1/fr active Granted
- 1977-11-25 DE DE2752728A patent/DE2752728C2/de not_active Expired
- 1977-11-25 SE SE7713370A patent/SE426781B/sv not_active IP Right Cessation
- 1977-11-25 DK DK523277A patent/DK150534C/da not_active IP Right Cessation
- 1977-11-25 PT PT67323A patent/PT67323B/pt unknown
- 1977-11-25 IE IE2391/77A patent/IE45998B1/en not_active IP Right Cessation
- 1977-11-25 AR AR270132A patent/AR218047A1/es active
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB824337A (en) * | 1955-08-08 | 1959-11-25 | R J Strasenburgh Co | Therapeutic compositions |
| US3153613A (en) * | 1957-02-13 | 1964-10-20 | Ici Ltd | Tetra-and penta-methyl piperidine antihypertensive compositions and therapy |
| US3158538A (en) * | 1961-02-23 | 1964-11-24 | White Lab Inc | Antidiarrheal compositions and method of using |
| GB982150A (en) * | 1961-09-29 | 1965-02-03 | Glaxo Group Ltd | Therapeutic resin complexes |
| US3594470A (en) * | 1968-02-19 | 1971-07-20 | Abbott Lab | Chewable tablets including coated particles of pseudoephedrine-weak cation exchange resin |
| FR2004105A1 (fr) * | 1968-03-15 | 1969-11-21 | Philips Nv | Preparations pharmaceutiques |
| DE1944693A1 (de) * | 1968-09-03 | 1970-04-30 | Banker Dr Gilbert S | Arzneimittelzubereitung |
| DE1944694A1 (de) * | 1968-09-03 | 1970-05-06 | Banker Dr Gilbert S | Pharmazeutische Zubereitung |
| FR2242076A1 (enExample) * | 1973-08-28 | 1975-03-28 | Hoechst Ag |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2373288A1 (fr) | Preparation pharmaceutique a liberation prolongee | |
| NO166267C (no) | Konjugat av et maalsoekende biologisk aktivt molekyl og en forbindelse inneholdende spormerkende metall, samt diagnostisk preparat inneholdende konjugatet. | |
| NO854786L (no) | Roterende anordning for behandling av smeltet metall. | |
| OA05234A (fr) | Nouveaux dérivés de l'imidazole, procédés pour leur préparation et application en tant qu'agents fongicides. | |
| NO870893L (no) | Apparat for behandling av smeltet metall. | |
| NO179008C (no) | Analogifremgangsmåte ved fremstilling av terapeutisk aktive metallkompleksforbindelser | |
| FR2374916A1 (fr) | Nouvelles compositions pharmaceutiques comprenant comme vehicule un ou plusieurs isosorbides | |
| CA2149055A1 (fr) | Compositions antitumorales contenant des derives du taxane | |
| SE8202172L (sv) | Topiska farmaceutiska kompositioner | |
| DE69531613D1 (de) | Einführung einer thiol-gruppe in proteine für die radioimmundetektion und radioimmuntherapie auf der basis von radionukliden | |
| FR2382234A1 (fr) | Comprime a vitesse d'elution constante et son procede de fabrication | |
| IT8323205A0 (it) | Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene. | |
| SE7710326L (sv) | Legering for behandling av smelt metall | |
| DK400785D0 (da) | Praeparat med forlaenget afgivelse | |
| FR2534907B1 (fr) | Complexes diamine-platine, un procede pour leur preparation, un procede pour la preparation d'une composition medicinale utilisant un tel complexe diamine platine pour le traitement du cancer ainsi que la composition ainsi formee | |
| FR2362622A1 (fr) | Nouveaux agents radiodiagnostiques et leur preparation | |
| OA05575A (fr) | Nouveaux dérivés d'indolizine, leur procédé de préparation ainsi que les compositions les contenant. | |
| IT8323396A0 (it) | Antimuscarinica. composizione farmaceutica adattivita' sistemica anticolinesterasica, agonista-colinergica ed | |
| DK676987D0 (da) | Nasaloploesninger | |
| FR2570278B1 (fr) | Compositions et procede pour proteger les lymphocytes t contre l'agent etiologique des lymphadenopathies et du syndrome d'immunodepression acquise | |
| FR2550944B1 (fr) | Association pharmaceutique a base d'anticorps anticellules tumorales et de conjugues cytotoxiques, appropriee notamment pour le traitement des cancers | |
| FR2335950A1 (fr) | Procede pour realiser la diffusion d'une impurete dans un corps semi-conducteur | |
| BE845709R (fr) | Composition pharmaceutique contenant du 1, 3-bis (2-carboxychromone-5-yloxy)-2-hydroxypropane pour le traitement de l'ulcere de la bouche | |
| DK464483A (da) | Fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende et fibrinolytisk middel | |
| NL7508897A (nl) | Edelmetaalhoudende bekledingsmassa's. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse | ||
| AR | Application made for restoration | ||
| BR | Restoration of rights | ||
| TP | Transmission of property |